Prognostic role of TLR4 and TLR2 in hepatocellular carcinoma.

Kairaluoma, Valtteri; Kemi, Niko; Huhta, Heikki; Pohjanen, Vesa-Matti; Helminen, Olli

Kairaluoma, Valtteri; Kemi, Niko; Huhta, Heikki; Pohjanen, Vesa-Matti; Helminen, Olli.

Afiliação

Kairaluoma V; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Kemi N; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Huhta H; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Pohjanen VM; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Helminen O; Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.

Acta Oncol ; 60(4): 554-558, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33502274

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Prognóstico; Receptor 2 Toll-Like; Receptor 4 Toll-Like

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Acta Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google